PHASE I TRIAL OF AdRSVtk VIRUS WITH GANCICLOVIR IN 
PATIENTS WITH UNRESECTABLE MALIGNANT 
MESOTHELIOMA 
UPCC 2594 
VOLUNTARY CONSENT 
I have read this consent for, or it has been read to me Any questions I have concerning this study 
have been answered, I understand that if I wish further information regarding my rights as a research 
subject, I may contact the Director in the Office of Research Administration at the University of 
Pennsylvania by calling 215-898-7293 
My signature below means that I am freely giving my permission to participate in this study and that 
I have received a copy of this informed consent. 
Name of Subject Signature of Subject Date 
I have explained this consent form and the nature of this study to the patient. I have explained all 
possible risks and potential benefits, and have answered any questions asked by the subject 
Name of Investigator Signature of Investigator Date 
Name of Witness Signature of Witness Date 
Recombinant DNA Research, Volume 20 
[421] 
